MENU
Articles by #hashtag

Pharmaceutical industry

24 hits

Pandemic Crisis Management at Gedeon Richter

D&T
May 10, 2021

As the world enters into the second year of the COVID-19 pandemic, the Hungarian pharmaceutical company Gedeon Richter Plc. continues to regularly provide a brief update of its impact on the health and wellbeing of its employees and its operations at large. According to OECD Statistics, global GDP declined by 4.2 % in 2020 due […]

Roche to Enlarge SSC Center in Budapest

D&T
Apr 15, 2021

The Switzerland-based pharmaceutical company Roche is going to increase the number of its collaborators in positions creating high added value in its service center located in the Hungarian capital. The 250 new employees will provide support to the subsidiaries of Roche in 60 countries in the fields of finance, purchasing, HR and information technology. Roche […]

Pharma factory Built to Produce Coronavirus Pills

D&T
Mar 11, 2021

A plant built with state subsidy by the pharma company Meditop in Pilisborosjenő, NW of Budapest, was inaugurated this Thursday, It will be here that preparations used to treat coronavirus patients are manufactured and developed. During the inauguration ceremony, Minister of Finance Mihály Varga was of the view that thanks to the Health Support Program, […]

Gedeon Richter Maintains Strategic Direction

D&T
Feb 26, 2021

In its 2020 report to the Budapest Stock Exchange, the Hungarian pharmaceutical company Gedeon Richter Plc. states that the company managed to service its customers on time and in full also into the last quarter of the reported year despite a sharp increase in COVID-19 case numbers in its countries of operation. Additional protective measures […]

Hungarian-Belgian Pharmaceutical Agreement

D&T
Dec 23, 2020

The Hungarian pharmaceutical company Richter and the Belgian pharma firm Mithra strengthen their partnership with the signing of a license and supply agreement for the commercialization of a novel oral contraceptive to Latin America. Gedeon Richter Plc. and Estetra S.A, the wholly owned subsidiary of Mithra Pharmaceuticals, have announced that they extended their partnership and […]

Sanofi Increasing Production Capacity in NE Hungary

D&T
Oct 19, 2020

Hungary's second largest healthcare company, Sanofi, is investing about EUR 22 million euros (approx. HUF 7.9 billion) in its Miskolc plant, increasing its production capacity for pre-filled syringes by 50%. The Hungarian government contributes HUF 1.2 billion to wards the investment. Following the investments of the past years, Sanofi is now launching another significant expansion […]

Béres Pharmaceuticals in Szolnok

Béres Pharmaceuticals Expands in Szolnok

D&T
Oct 15, 2020

The foundation stone of a new production facility for Béres Pharmaceuticals was laid this Thursday in Szolnok E Hungary. The Hungarian pharma firm is expanding its activities in Szolnok with an investment of more than HUF 6 billion (which is currently close to EUR 17 million). Finance Minister Mihály Varga announced at the ceremony that […]

Doing Now What Patients Need Next

Sándor Laczkó
Oct 3, 2020

Providing medical solutions that improve people’s quality of life on a daily basis, while also constantly working on the innovations of the future – this dual mission of the Swiss multinational healthcare company Roche is also the driving force for the management and staff of the Hungarian subsidiary established back in 1984. Roche is the […]

Richter Share Price Breaks Record

D&T
Aug 24, 2020

A three-year price record for the shares of the Hungarian pharmaceutical company Gedeon Richter was broken on Monday: the price rose above HUF 7,300 at the Budapest Stock Exchange. The company is one of the winners of the coronavirus epidemic, it is helped by the weakening of the Hungarian currency, and its sales are not […]

Sales Related Milestone at Gedeon Richter

D&T
Aug 3, 2020

For the first time in history, an original molecule invented by a CEE headquartered pharmaceutical company (Gedeon Richter's Vraylar), reached blockbuster status in the USA in the first half of 2020. "Thanks to the outstanding performance of our trusted partner Abbvie, Vraylar’s turnover exceeded USD 1 billion in Q2, which triggered the receipt of a […]

Korean Ambassador Kyoo Sik Choe and Hungarian Minister for Foreign Affiars and Trade, Péter Szijjártó (on the left) at the announcement

Samyang Biopharm: First European Unit in Gödöllő

D&T
Jul 29, 2020

South Korea-based Samyang Biopharm, specializing in medical devices, has selected Hungary for its first production unit in Europe. The HUF 8.6 billion (EUR 26.2 million) unit, will produce synthetic suture materials and create 55 new jobs in Gödöllő. The Hungarian government contributes about 15% of that amount (HUF 1.3 billion) in non-refundable support. The South […]

Reagila, developed in Hungary, Medicine of the Year

D&T
Jun 12, 2020

Richter's atypical antipsychotic, Reagila, containing the active ingredient cariprazine, was awarded the title of Drug of the Year 2019 by the Hungarian Society for Experimental and Clinical Pharmacology (HUNPHAR). Each year, the prestigious award recognizes the most advanced and effective products that have made a significant breakthrough in the cure of a disease. The award […]

Clinical Trials and the Quest for New Drugs

Viktória Villányi
May 12, 2020

The global quest for effective treatment for the quickly spreading COVID -19 pandemic demands a review and amendment of the regulations on clinical trials carried out on human subjects. To expedite market access to rapid tests, vaccines, and newly developed drugs, both the US FDA and the European Medicines Agency (EMA) have recently published recommendations […]

Rising Profits and Sales at Richter Gedeon Plc.

D&T
May 8, 2020

Sales and profit grew well above analysts' expectations in the first quarter of this year for the Hungarian pharmaceutical company Richter Gedeon Plc. The firm achieved a consolidated after tax profit of HUF 29.1 billion, which is 34.6% higher than in the same period of the previous year, and its sales revenue increased by 16.3% […]

GSK vaccine plant in Gödöllő

Vaccine Manufacturing Volume Increases in Gödöllő

D&T
Nov 14, 2019

As a result of the latest development of GlaxoSmithKline (GSK), the operations of its Hungarian factory in Gödöllő, east of Budapest have been extended to manufacture diphtheria and tetanus vaccine components for a new area of application. GlaxoSmithKline was established in 2001 by the merger of GlaxoWellcome, a company with a century-long history, and SmithKline […]

© Copyright 2021 Duax Kft. –  All rights reserved.
sun